Quick Summary
Covering the latest research from top Wall Street investment banks

Greentown China’s recovery path is long and uncertain, and Morgan Stanley maintains an Underweight rating

Institution
Morgan Stanley
Date
2026-04-06
Authors
Stephen Cheung, CFA, Cara Zhu
Company
Greentown China Holdings
Ticker
3900.HK
Industry
Property Development
Rating
Underweight
BearishLow confidenceMorgan Stanley believes that Greentown China’s sales, margins, and management turnover pressure will make earnings recovery take longer than the market expects, with the target price implying about 15% downside from the current share price.
AuthorsStephen Cheung, CFA, Cara Zhu
Target priceHK$7.15
CoverageAsia-Pacific
Asset classesEquity
SubsidiariesGreentown Management
Business segmentsdevelopment properties、project management business、investment properties
Research firm divisions/subsidiariesMorgan Stanley(Other)、Morgan Stanley Asia Limited(Other)

AI summary card

Greentown China’s recovery path is long and uncertain, and Morgan Stanley maintains an Underweight rating

The report argues that Greentown China’s 2026 saleable resources, attributable sales, and margins will remain under pressure, and management changes could further slow land acquisition and sales recovery, leading to a 9% cut in target price to HK$7.15.

Rating: Underweight; Target price: HK$7.15; Implied downside: about 15%; Time horizon: 12-18 months.
Maintain UnderweightTarget Price HK$7.152026 Sales Under PressureSlow Margin RecoveryManagement Change Uncertainty
  • Morgan Stanley expects total contracted sales in 2026 to fall by about 15% YoY, while attributable sales could decline by more than 20% because saleable resources are shrinking, the attributable share of land acquisitions is falling, and carryover sales are decreasing.
  • Core profit estimates were cut: 2026 and 2027 are lowered by 12% and 11% to Rmb677mn and Rmb1.5bn, respectively; revenue estimates are lowered by 5% and 10%.
  • The valuation uses a 2026e NAV approach. With NAV at HK$11.92/share and a 40% discount maintained, the target price is HK$7.15/share, down 9% from before.
  • The report believes the current valuation of about 28x 2026e core profit and 0.5x trailing P/B is expensive versus the sector average, while future ROE is only about 2%-4%.

Report interpretation

Overview

This is a company research and earnings review report on Greentown China Holdings (3900.HK). Morgan Stanley believes that although the company may turn from loss to profit in 2026, sales scale, revenue recognition, destocking of older projects, and margin recovery all face pressure. A return to normal profitability may take several years and could even be delayed until after 2030. The report maintains an Underweight rating and lowers the target price to HK$7.15.

Core views

The core view is: first, the pre-sales outlook is weak, with 2026 total contracted sales expected to fall by about 15% YoY, and attributable contracted sales likely to decline even more because the attributable share of new land acquisitions has fallen; second, management turnover creates near-term operating and financial uncertainty, and the new CEO has not yet arrived, which may make the company more cautious on land acquisition price and scale; third, margin recovery is slower than expected, with old projects accounting for about 50% of unsold land bank, and prices may still need to be cut amid falling home prices and active destocking; fourth, the current valuation is expensive relative to the sector and does not fully reflect sales, ROE, and management uncertainty.

Analysis framework

The report starts from sales resources, the attributable share of land acquisitions, carryover sales, margin assumptions, and changes in revenue and core profit forecasts to reassess Greentown China’s earnings path for 2026-2027; it then uses sum-of-the-parts and NAV discount valuation, and combines the developer scorecard to determine the NAV discount level.

Methodology notes

  • Valuation methodsNAV discount method

    Base the target price on 2026e NAV and apply a discount

    Morgan Stanley cut Greentown China’s 2026e NAV estimate by 9% to HK$11.92/share and kept a 40% NAV discount, resulting in a target price of HK$7.15/share.

  • Valuation methodsSOTP

    Sum-of-the-parts valuation

    NAV is made up of development properties, the project management business, and net debt, with development properties at HK$18.33/share, the project management business at HK$1.30/share, and net debt at HK$7.70/share.

  • Valuation methodsDCF

    Discounted cash flow valuation for development properties

    The report values development properties using DCF, with WACC at 8.3%, down from 9.2% previously, reflecting lower financing costs.

  • Valuation methodsCap rate

    Capitalization of investment property income

    The report values investment properties using a 5%-8% NOI capitalization rate.

  • Scoring frameworkDevelopers' scorecard

    Developer scorecard determines the NAV discount

    The scorecard covers land bank, execution, scale, growth, profitability, financing, and leverage; based on this, the report keeps a 40% NAV discount.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

  • Greentown China Holdings (3900.HK)
    Covered company, Hong Kong-listed equity asset
    Strengths
    Financing capacity and leverage scores are relatively strong, with a financing score of 9/10 and a leverage score of 8/10; some recent projects have had better margins, which may support margin improvement after 2028e.
    Weaknesses
    Saleable resources are shrinking, the attributable share of land acquisitions is falling, and carryover sales are declining, putting pressure on revenue and attributable sales over the next few years; old projects account for about 50% of unsold land bank, and destocking may weigh on margins.
    Comparison
    The report sees the stock’s 28x 2026e core profit and 0.5x trailing P/B as expensive relative to the sector average, while future ROE of only about 2%-4% is below peers.
    Risks
    Management change, weaker sales, slower land acquisition, further home price declines, and slower-than-expected margin recovery.
  • Chinese property developers sector
    Industry backdrop and relative valuation peer set
    Strengths
    If credit and property policy ease materially, housing demand, asset prices, and developer liquidity could improve.
    Weaknesses
    The industry still faces falling home prices, weak sales, and liquidity pressure on developers.
    Comparison
    Although Greentown China has better financing conditions, the report believes its growth, profitability, and valuation risk/reward are unattractive.
    Risks
    Insufficient policy easing could trigger more developer defaults and more aggressive price cuts, further depressing sector sentiment.

Key data

  • Target priceHK$7.15/shareDown 9% from before, derived by applying a 40% discount to the 2026e NAV of HK$11.92/share.
  • Implied downsideabout 15%Relative to the current share price cited in the report.
  • 2026 revenue forecastRmb127bnForecast cut by 5%, reflecting project carryover changes and slower sales.
  • 2027 revenue forecastRmb102bnForecast cut by 10%.
  • 2026 core profit forecastRmb677mnForecast cut by 12%.
  • 2027 core profit forecastRmb1.5bnForecast cut by 11%.
  • 2026 gross margin assumption12.0%Raised by 0.6 percentage points, because the large asset impairment in 2025 provides some buffer for later margins.
  • 2027 gross margin assumption12.5%Raised by 0.3 percentage points.
  • 2026-2027 development business gross margin range10%-12%The report expects margins to remain low in the near term, and 2028e may recover to 13%-15%.
  • 2026 total sales forecastabout 15% YoY declineMainly because saleable resources fell to Rmb163bn, down 19% YoY.
  • Unrecognized attributable salesRmb107bnDown 25% YoY, creating pressure on future revenue recognition.
  • Attributable ratio of new land bank69%The 2025 attributable ratio of new land bank is lower than the 81% in 2024, which may deepen the decline in attributable sales.
  • Current valuation28x 2026e core profit, 12x 2027e core profit, 0.5x trailing P/BThe report considers it expensive relative to the sector average.
  • Bull case valueHK$9.54Based on a 20% NAV discount.
  • Bear case valueHK$4.77Based on a 60% NAV discount.

Impact & implications

The report is negative for Greentown China: earnings forecasts and the target price have been cut, and the market’s expectation for a near-term turn from loss to profit may not be enough to offset shrinking sales scale, margin drag from destocking older projects, and uncertainty from management changes. For investors, the report highlights that the stock needs a stronger sales recovery, margin repair, or policy easing to improve the risk/reward profile.

Risks

  • Upside risks include faster-than-expected recovery in development margins, stronger-than-expected contracted sales growth, and higher-than-expected dividend payouts.
  • Downside risks include weaker-than-expected contracted sales, slower-than-expected land acquisition, and weaker-than-expected construction and delivery progress.
  • If easing in credit and real-estate policy is insufficient, developer liquidity may continue to deteriorate and trigger further price cuts.
  • Management changes may create uncertainty around land investment, operating execution, and financial performance.
  • Destocking of older projects and falling home prices may continue to suppress gross margin recovery.

What to watch

  • Whether 2026-2027 contracted sales and attributable contracted sales fall more than expected.
  • The land acquisition strategy, land price discipline, and attributable ratio after the new CEO takes office.
  • The pace of destocking older projects and the impact of discounting on gross margin.
  • Home price trends in first-tier, second-tier, and lower-tier cities, especially the report’s base-case assumption of YoY declines after the end of 2025.
  • The力度 of policy easing, including purchase restrictions, down-payment ratios, mortgage rates, developer loans, pre-sale permit approvals, and price caps.
  • Whether 2026-2027 revenue recognition, core profit, and ROE can meet the revised forecasts.
Zhejiang ICP No. 2022035445-5
Disclaimer: Market data, charts, indicators, research views, and other information provided on this website are intended solely for information display, research communication, and educational reference. They should not be regarded as personalized investment advice, securities recommendations, trading instructions, solicitations, or guarantees of return. While we strive to improve the reliability of our data and content, such information may still be subject to delays, errors, incompleteness, or untimely updates due to source differences, methodological limitations, system processing, or market volatility. Users should exercise independent judgment based on their own circumstances and bear all risks and responsibilities arising from the use of this website.

Settings

Sign in to view recent logins